Review



panc 1  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC panc 1
    In vitro evaluation <t>of</t> <t>Panc-1</t> and Pan02 cells after different treatments. (A) Colony formation assay of Panc-1 and Pan02 cells after different treatments. (B) Quantification of colony numbers of Panc-1 and Pan02 cells under the indicated treatments. (C) Representative images of cell migration of Panc-1 and Pan02 cells after different treatments. (D) Quantification of residual area of Panc-1 and Pan02 cells in each group. (E) ROS fluorescence intensity of Panc-1 cells after different treatments. (F) ROS fluorescence intensity of Pan02 cells after different treatments. (G) Viability of Panc-1 cells co-cultured with L929 cells in a transwell system after different treatments. (H) Viability of Pan02 cells co-cultured with L929 cells in a transwell system after different treatments. (I) Representative CLSM images of Panc-1 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups (scale bar: 200 μm). (J) Representative CLSM images of Pan02 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups. (K) Immunofluorescence staining of uPA in Panc-1 cells after different treatments.(scale bar:100 μm). (L) Immunofluorescence staining of uPA in Pan02 cells after different treatments. Data are presented as mean ± standard deviation (SD), n = 3. Statistical significance was analyzed by one-way ANOVA with t -test; ns, not significant; ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Panc 1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 7842 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/panc 1/product/ATCC
    Average 99 stars, based on 7842 article reviews
    panc 1 - by Bioz Stars, 2026-06
    99/100 stars

    Images

    1) Product Images from "Stromal homeostasis-restoring “rocket-like” nanomedicine inhibited pancreatic tumor growth in vivo"

    Article Title: Stromal homeostasis-restoring “rocket-like” nanomedicine inhibited pancreatic tumor growth in vivo

    Journal: Materials Today Bio

    doi: 10.1016/j.mtbio.2026.103014

    In vitro evaluation of Panc-1 and Pan02 cells after different treatments. (A) Colony formation assay of Panc-1 and Pan02 cells after different treatments. (B) Quantification of colony numbers of Panc-1 and Pan02 cells under the indicated treatments. (C) Representative images of cell migration of Panc-1 and Pan02 cells after different treatments. (D) Quantification of residual area of Panc-1 and Pan02 cells in each group. (E) ROS fluorescence intensity of Panc-1 cells after different treatments. (F) ROS fluorescence intensity of Pan02 cells after different treatments. (G) Viability of Panc-1 cells co-cultured with L929 cells in a transwell system after different treatments. (H) Viability of Pan02 cells co-cultured with L929 cells in a transwell system after different treatments. (I) Representative CLSM images of Panc-1 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups (scale bar: 200 μm). (J) Representative CLSM images of Pan02 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups. (K) Immunofluorescence staining of uPA in Panc-1 cells after different treatments.(scale bar:100 μm). (L) Immunofluorescence staining of uPA in Pan02 cells after different treatments. Data are presented as mean ± standard deviation (SD), n = 3. Statistical significance was analyzed by one-way ANOVA with t -test; ns, not significant; ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Figure Legend Snippet: In vitro evaluation of Panc-1 and Pan02 cells after different treatments. (A) Colony formation assay of Panc-1 and Pan02 cells after different treatments. (B) Quantification of colony numbers of Panc-1 and Pan02 cells under the indicated treatments. (C) Representative images of cell migration of Panc-1 and Pan02 cells after different treatments. (D) Quantification of residual area of Panc-1 and Pan02 cells in each group. (E) ROS fluorescence intensity of Panc-1 cells after different treatments. (F) ROS fluorescence intensity of Pan02 cells after different treatments. (G) Viability of Panc-1 cells co-cultured with L929 cells in a transwell system after different treatments. (H) Viability of Pan02 cells co-cultured with L929 cells in a transwell system after different treatments. (I) Representative CLSM images of Panc-1 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups (scale bar: 200 μm). (J) Representative CLSM images of Pan02 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups. (K) Immunofluorescence staining of uPA in Panc-1 cells after different treatments.(scale bar:100 μm). (L) Immunofluorescence staining of uPA in Pan02 cells after different treatments. Data are presented as mean ± standard deviation (SD), n = 3. Statistical significance was analyzed by one-way ANOVA with t -test; ns, not significant; ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Techniques Used: In Vitro, Colony Assay, Migration, Fluorescence, Cell Culture, Staining, Immunofluorescence, Standard Deviation



    Similar Products

    panc 1  (ATCC)
    99
    ATCC panc 1
    In vitro evaluation <t>of</t> <t>Panc-1</t> and Pan02 cells after different treatments. (A) Colony formation assay of Panc-1 and Pan02 cells after different treatments. (B) Quantification of colony numbers of Panc-1 and Pan02 cells under the indicated treatments. (C) Representative images of cell migration of Panc-1 and Pan02 cells after different treatments. (D) Quantification of residual area of Panc-1 and Pan02 cells in each group. (E) ROS fluorescence intensity of Panc-1 cells after different treatments. (F) ROS fluorescence intensity of Pan02 cells after different treatments. (G) Viability of Panc-1 cells co-cultured with L929 cells in a transwell system after different treatments. (H) Viability of Pan02 cells co-cultured with L929 cells in a transwell system after different treatments. (I) Representative CLSM images of Panc-1 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups (scale bar: 200 μm). (J) Representative CLSM images of Pan02 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups. (K) Immunofluorescence staining of uPA in Panc-1 cells after different treatments.(scale bar:100 μm). (L) Immunofluorescence staining of uPA in Pan02 cells after different treatments. Data are presented as mean ± standard deviation (SD), n = 3. Statistical significance was analyzed by one-way ANOVA with t -test; ns, not significant; ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Panc 1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/panc 1/product/ATCC
    Average 99 stars, based on 1 article reviews
    panc 1 - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC experimental models u2 os ecacc 92022711 panc 1 ecacc
    In vitro evaluation <t>of</t> <t>Panc-1</t> and Pan02 cells after different treatments. (A) Colony formation assay of Panc-1 and Pan02 cells after different treatments. (B) Quantification of colony numbers of Panc-1 and Pan02 cells under the indicated treatments. (C) Representative images of cell migration of Panc-1 and Pan02 cells after different treatments. (D) Quantification of residual area of Panc-1 and Pan02 cells in each group. (E) ROS fluorescence intensity of Panc-1 cells after different treatments. (F) ROS fluorescence intensity of Pan02 cells after different treatments. (G) Viability of Panc-1 cells co-cultured with L929 cells in a transwell system after different treatments. (H) Viability of Pan02 cells co-cultured with L929 cells in a transwell system after different treatments. (I) Representative CLSM images of Panc-1 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups (scale bar: 200 μm). (J) Representative CLSM images of Pan02 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups. (K) Immunofluorescence staining of uPA in Panc-1 cells after different treatments.(scale bar:100 μm). (L) Immunofluorescence staining of uPA in Pan02 cells after different treatments. Data are presented as mean ± standard deviation (SD), n = 3. Statistical significance was analyzed by one-way ANOVA with t -test; ns, not significant; ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Experimental Models U2 Os Ecacc 92022711 Panc 1 Ecacc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/experimental models u2 os ecacc 92022711 panc 1 ecacc/product/ATCC
    Average 99 stars, based on 1 article reviews
    experimental models u2 os ecacc 92022711 panc 1 ecacc - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    86
    Procell Inc panc 1 cell lines
    In vitro evaluation <t>of</t> <t>Panc-1</t> and Pan02 cells after different treatments. (A) Colony formation assay of Panc-1 and Pan02 cells after different treatments. (B) Quantification of colony numbers of Panc-1 and Pan02 cells under the indicated treatments. (C) Representative images of cell migration of Panc-1 and Pan02 cells after different treatments. (D) Quantification of residual area of Panc-1 and Pan02 cells in each group. (E) ROS fluorescence intensity of Panc-1 cells after different treatments. (F) ROS fluorescence intensity of Pan02 cells after different treatments. (G) Viability of Panc-1 cells co-cultured with L929 cells in a transwell system after different treatments. (H) Viability of Pan02 cells co-cultured with L929 cells in a transwell system after different treatments. (I) Representative CLSM images of Panc-1 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups (scale bar: 200 μm). (J) Representative CLSM images of Pan02 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups. (K) Immunofluorescence staining of uPA in Panc-1 cells after different treatments.(scale bar:100 μm). (L) Immunofluorescence staining of uPA in Pan02 cells after different treatments. Data are presented as mean ± standard deviation (SD), n = 3. Statistical significance was analyzed by one-way ANOVA with t -test; ns, not significant; ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Panc 1 Cell Lines, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/panc 1 cell lines/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    panc 1 cell lines - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    99
    ATCC pancreatic cancer cell culture panc 1
    In vitro evaluation <t>of</t> <t>Panc-1</t> and Pan02 cells after different treatments. (A) Colony formation assay of Panc-1 and Pan02 cells after different treatments. (B) Quantification of colony numbers of Panc-1 and Pan02 cells under the indicated treatments. (C) Representative images of cell migration of Panc-1 and Pan02 cells after different treatments. (D) Quantification of residual area of Panc-1 and Pan02 cells in each group. (E) ROS fluorescence intensity of Panc-1 cells after different treatments. (F) ROS fluorescence intensity of Pan02 cells after different treatments. (G) Viability of Panc-1 cells co-cultured with L929 cells in a transwell system after different treatments. (H) Viability of Pan02 cells co-cultured with L929 cells in a transwell system after different treatments. (I) Representative CLSM images of Panc-1 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups (scale bar: 200 μm). (J) Representative CLSM images of Pan02 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups. (K) Immunofluorescence staining of uPA in Panc-1 cells after different treatments.(scale bar:100 μm). (L) Immunofluorescence staining of uPA in Pan02 cells after different treatments. Data are presented as mean ± standard deviation (SD), n = 3. Statistical significance was analyzed by one-way ANOVA with t -test; ns, not significant; ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Pancreatic Cancer Cell Culture Panc 1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pancreatic cancer cell culture panc 1/product/ATCC
    Average 99 stars, based on 1 article reviews
    pancreatic cancer cell culture panc 1 - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC pancreatic cancer cell line panc
    ( A ) Mitochondrial oxygen consumption rate (OCR) and ( B ) extracellular acidification rate (ECAR) in KRAS* cells 4 h after 10p IRE or 20p IRE (400 V). ( C ) Effect of IRE on mitochondrial ATP production. Data are normalized to cell number at the end of the assay (pmol/min/1000 cells). Data are expressed as mean ± SD (n=6/group). *p<0.05, **p<0.01, ***p<0.001 (one-way ANOVA). ( D ) Representative confocal fluorescence microscopic images of cytoplasmic dsDNA and corresponding quantification of fluorescence (FL) signal intensity in cytosol and <t>nuclei.</t> <t>PANC-1</t> cells were stained with PicoGreen for dsDNA 24 h after IRE (400 V, 20 pulses). Untreated cells were used as a control. The negative control was cells not stained with PicoGreen. Data are expressed as mean ± SD (n=4). *p<0.05, *p<0.01, (Student’s t test). ( E ) Analysis of dsDNA from IRE-treated KRAS* tumors using the Qubit dsDNA HS assay kits. KRAS* tumor tissues were collected on day 1 and day 4 after IRE (1200 V, 99 pulses) and processed for dsDNA assays. *p<0.05, ****p<0.0001 (Student’s t test). ( F ) Real-time PCR analysis of the interferon-stimulated genes Irf1 , Cxcl10 , and Isg15 downstream of the cGAS-STING pathway. KRAS* cells were collected 4 h after IRE (400 V, 20 pulses). *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (one-way ANOVA). Data are expressed as mean ± SD (n=3/group).
    Pancreatic Cancer Cell Line Panc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pancreatic cancer cell line panc/product/ATCC
    Average 99 stars, based on 1 article reviews
    pancreatic cancer cell line panc - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC human pancreatic carcinoma cells panc 1
    ( A ) Mitochondrial oxygen consumption rate (OCR) and ( B ) extracellular acidification rate (ECAR) in KRAS* cells 4 h after 10p IRE or 20p IRE (400 V). ( C ) Effect of IRE on mitochondrial ATP production. Data are normalized to cell number at the end of the assay (pmol/min/1000 cells). Data are expressed as mean ± SD (n=6/group). *p<0.05, **p<0.01, ***p<0.001 (one-way ANOVA). ( D ) Representative confocal fluorescence microscopic images of cytoplasmic dsDNA and corresponding quantification of fluorescence (FL) signal intensity in cytosol and <t>nuclei.</t> <t>PANC-1</t> cells were stained with PicoGreen for dsDNA 24 h after IRE (400 V, 20 pulses). Untreated cells were used as a control. The negative control was cells not stained with PicoGreen. Data are expressed as mean ± SD (n=4). *p<0.05, *p<0.01, (Student’s t test). ( E ) Analysis of dsDNA from IRE-treated KRAS* tumors using the Qubit dsDNA HS assay kits. KRAS* tumor tissues were collected on day 1 and day 4 after IRE (1200 V, 99 pulses) and processed for dsDNA assays. *p<0.05, ****p<0.0001 (Student’s t test). ( F ) Real-time PCR analysis of the interferon-stimulated genes Irf1 , Cxcl10 , and Isg15 downstream of the cGAS-STING pathway. KRAS* cells were collected 4 h after IRE (400 V, 20 pulses). *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (one-way ANOVA). Data are expressed as mean ± SD (n=3/group).
    Human Pancreatic Carcinoma Cells Panc 1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human pancreatic carcinoma cells panc 1/product/ATCC
    Average 99 stars, based on 1 article reviews
    human pancreatic carcinoma cells panc 1 - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    Image Search Results


    In vitro evaluation of Panc-1 and Pan02 cells after different treatments. (A) Colony formation assay of Panc-1 and Pan02 cells after different treatments. (B) Quantification of colony numbers of Panc-1 and Pan02 cells under the indicated treatments. (C) Representative images of cell migration of Panc-1 and Pan02 cells after different treatments. (D) Quantification of residual area of Panc-1 and Pan02 cells in each group. (E) ROS fluorescence intensity of Panc-1 cells after different treatments. (F) ROS fluorescence intensity of Pan02 cells after different treatments. (G) Viability of Panc-1 cells co-cultured with L929 cells in a transwell system after different treatments. (H) Viability of Pan02 cells co-cultured with L929 cells in a transwell system after different treatments. (I) Representative CLSM images of Panc-1 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups (scale bar: 200 μm). (J) Representative CLSM images of Pan02 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups. (K) Immunofluorescence staining of uPA in Panc-1 cells after different treatments.(scale bar:100 μm). (L) Immunofluorescence staining of uPA in Pan02 cells after different treatments. Data are presented as mean ± standard deviation (SD), n = 3. Statistical significance was analyzed by one-way ANOVA with t -test; ns, not significant; ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Materials Today Bio

    Article Title: Stromal homeostasis-restoring “rocket-like” nanomedicine inhibited pancreatic tumor growth in vivo

    doi: 10.1016/j.mtbio.2026.103014

    Figure Lengend Snippet: In vitro evaluation of Panc-1 and Pan02 cells after different treatments. (A) Colony formation assay of Panc-1 and Pan02 cells after different treatments. (B) Quantification of colony numbers of Panc-1 and Pan02 cells under the indicated treatments. (C) Representative images of cell migration of Panc-1 and Pan02 cells after different treatments. (D) Quantification of residual area of Panc-1 and Pan02 cells in each group. (E) ROS fluorescence intensity of Panc-1 cells after different treatments. (F) ROS fluorescence intensity of Pan02 cells after different treatments. (G) Viability of Panc-1 cells co-cultured with L929 cells in a transwell system after different treatments. (H) Viability of Pan02 cells co-cultured with L929 cells in a transwell system after different treatments. (I) Representative CLSM images of Panc-1 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups (scale bar: 200 μm). (J) Representative CLSM images of Pan02 cells co-stained with Calcein-AM (green) and PI (red) after treatment with different groups. (K) Immunofluorescence staining of uPA in Panc-1 cells after different treatments.(scale bar:100 μm). (L) Immunofluorescence staining of uPA in Pan02 cells after different treatments. Data are presented as mean ± standard deviation (SD), n = 3. Statistical significance was analyzed by one-way ANOVA with t -test; ns, not significant; ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: Triethylamine (TEA, Sigma-Aldrich); Cetyltrimethylammonium bromide (CTAB, Xinyanbomei); Sodium salicylate (NaSal, Sigma-Aldrich); Tetraethyl orthosilicate (TEOS, CATO); 1,2-Bis(triethoxysilyl)ethane (BTES, Xinhengyan); Ethanol; Hydrochloric acid; Methanol; Gemcitabine (MedChemExpress); Ammonium bicarbonate (Coolaber); Urokinase-type plasminogen activator (Solarbio); CCK-8 kit (CWBIO); ROS staining kit (Poolyue); Calcein-AM/PI kit (DOJINDO); anti-uPA antibody (HUABIO); Calcium chloride (Supelco); Indocyanine green (zrbiorise); Dulbecco's modified Eagle medium (DMEM, Sigma-Aldrich); Panc-1, Pan02, and L929 cells (ATCC); Fluorescein isothiocyanate (FITC, Qisong); 4′,6-diamidino-2-phenylindole (DAPI, Solarbio); DUTP (Roche); IPR-803 (MCE).

    Techniques: In Vitro, Colony Assay, Migration, Fluorescence, Cell Culture, Staining, Immunofluorescence, Standard Deviation

    ( A ) Mitochondrial oxygen consumption rate (OCR) and ( B ) extracellular acidification rate (ECAR) in KRAS* cells 4 h after 10p IRE or 20p IRE (400 V). ( C ) Effect of IRE on mitochondrial ATP production. Data are normalized to cell number at the end of the assay (pmol/min/1000 cells). Data are expressed as mean ± SD (n=6/group). *p<0.05, **p<0.01, ***p<0.001 (one-way ANOVA). ( D ) Representative confocal fluorescence microscopic images of cytoplasmic dsDNA and corresponding quantification of fluorescence (FL) signal intensity in cytosol and nuclei. PANC-1 cells were stained with PicoGreen for dsDNA 24 h after IRE (400 V, 20 pulses). Untreated cells were used as a control. The negative control was cells not stained with PicoGreen. Data are expressed as mean ± SD (n=4). *p<0.05, *p<0.01, (Student’s t test). ( E ) Analysis of dsDNA from IRE-treated KRAS* tumors using the Qubit dsDNA HS assay kits. KRAS* tumor tissues were collected on day 1 and day 4 after IRE (1200 V, 99 pulses) and processed for dsDNA assays. *p<0.05, ****p<0.0001 (Student’s t test). ( F ) Real-time PCR analysis of the interferon-stimulated genes Irf1 , Cxcl10 , and Isg15 downstream of the cGAS-STING pathway. KRAS* cells were collected 4 h after IRE (400 V, 20 pulses). *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (one-way ANOVA). Data are expressed as mean ± SD (n=3/group).

    Journal: bioRxiv

    Article Title: The abscopal effect of IRE combined with anti–PD-1 achieves local ablation and systemic control of PDAC

    doi: 10.64898/2026.05.04.722535

    Figure Lengend Snippet: ( A ) Mitochondrial oxygen consumption rate (OCR) and ( B ) extracellular acidification rate (ECAR) in KRAS* cells 4 h after 10p IRE or 20p IRE (400 V). ( C ) Effect of IRE on mitochondrial ATP production. Data are normalized to cell number at the end of the assay (pmol/min/1000 cells). Data are expressed as mean ± SD (n=6/group). *p<0.05, **p<0.01, ***p<0.001 (one-way ANOVA). ( D ) Representative confocal fluorescence microscopic images of cytoplasmic dsDNA and corresponding quantification of fluorescence (FL) signal intensity in cytosol and nuclei. PANC-1 cells were stained with PicoGreen for dsDNA 24 h after IRE (400 V, 20 pulses). Untreated cells were used as a control. The negative control was cells not stained with PicoGreen. Data are expressed as mean ± SD (n=4). *p<0.05, *p<0.01, (Student’s t test). ( E ) Analysis of dsDNA from IRE-treated KRAS* tumors using the Qubit dsDNA HS assay kits. KRAS* tumor tissues were collected on day 1 and day 4 after IRE (1200 V, 99 pulses) and processed for dsDNA assays. *p<0.05, ****p<0.0001 (Student’s t test). ( F ) Real-time PCR analysis of the interferon-stimulated genes Irf1 , Cxcl10 , and Isg15 downstream of the cGAS-STING pathway. KRAS* cells were collected 4 h after IRE (400 V, 20 pulses). *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (one-way ANOVA). Data are expressed as mean ± SD (n=3/group).

    Article Snippet: The human pancreatic cancer cell line PANC-1 was purchased from American Type Culture Collection.

    Techniques: Fluorescence, Staining, Control, Negative Control, Real-time Polymerase Chain Reaction